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The two main proteolytic machineries of eukaryotic cells, lysosomes and proteasomes, receive sub-
strates by different routes. Polyubiquitination targets proteins for proteasomal degradation, whereas
autophagy delivers intracellular material for lysosomal hydrolysis. The importance of autophagy for
cell survival has long been appreciated, but more recently, its essential role in both innate and adap-
tive immunity has been characterized. Autophagy is now recognized to restrict viral infections and
replication of intracellular bacteria and parasites. Additionally, this pathway delivers cytoplasmic an-
tigens for MHC class II presentation to the adaptive immune system, which then in turn is able to reg-
ulate autophagy. At the same time, autophagy plays a role in the survival and the cell death of T cells.
Thus, the immune system utilizes autophagic degradation of cytoplasmic material, to both restrict
intracellular pathogens and regulate adaptive immunity.Introduction
Eukaryotic cells degrade proteins with two main hydrolytic
machineries, proteasomes and lysosomes. In both sys-
tems, catabolic activities are physically separated from in-
tracellular substrates—in proteasomes, by localization in
a barrel-shaped multiprotein complex and in lysosomes,
by its vesicular membrane. Therefore, access to the hy-
drolytic activities within these structures determines
whether a protein is degraded. For proteasomes, polyubi-
quitination allows substrates to gain access to the cata-
lytic chamber for proteolysis (Ciechanover et al., 1984).
For lysosomes, autophagy delivers intracellular constitu-
ents for degradation, but how autophagosome cargo is
selected remains unclear (De Duve and Wattiaux, 1966).
Although proteasomes degrade soluble short-lived pro-
teins, autophagy targets cell organelles and aggregates
of long-lived proteins for degradation (Henell et al., 1987).
Autophagy is composed of at least three distinct path-
ways: microautophagy, chaperone-mediated autophagy,
and macroautophagy (Mizushima and Klionsky, 2007).
Microautophagy involves budding of small cytosol-
containing vesicles, and this budding occurs directly into
the lysosomal lumen. During chaperone-mediated au-
tophagy, proteins are directly imported into lysosomes
via the LAMP-2a transporter (Cuervo and Dice, 1996;
Cuervo and Dice, 2000) assisted by cytosolic (Chiang
et al., 1989) and lysosomal (Agarraberes et al., 1997)
HSC70 chaperones. Substrates of chaperone-mediated
autophagy carry signal peptides for sorting into lyso-
somes, similar to other protein-transport mechanisms
across membranes (Agarraberes and Dice, 2001). Finally,
during macroautophagy, a cup-shaped isolation mem-
brane forms de novo from sources that are still debated
(Juhasz and Neufeld, 2006). In this process, cytosolic con-
stituents are enclosed in a double-membrane vesicle,called autophagosome (Fengsrud et al., 2000a; Strom-
haug et al., 1998), which then fuses with lysosomes and
late endosomes for degradation of the inner autophago-
somal membrane and its cargo (Ohsumi, 2001) (Figure 1).
The class III phosphatidylinositol 3-kinase (PI3K) and its
binding partner, the autophagy-related gene (Atg) 6 (also
known as Beclin-1), is required for the initiation of the iso-
lation membrane (Kihara et al., 2001; Zeng et al., 2006). In
addition, two ubiquitin-like systems are essential for the
formation of autophagosomes: In one of them, the five
C-terminal amino acids of the ubiquitin-like protein Atg8
(also known as light chain [LC] 3) are cleaved off by the
Atg4 protease to liberate a glycine residue (G120). This
C-terminal residue then gets transferred to phosphatidyl-
ethanolamine in the forming isolation membrane by the
E1- and E2-like enzymes Atg7 and Atg3. Although Atg8
(LC3) gets recycled from the outer autophagosomal mem-
brane by deconjugation from the phospholipid, it remains
attached to the inner autophagosomal membrane, and
this proportion is degraded with the inner autophagoso-
mal membrane in lysosomes and late endosomes after
fusion with these vesicles (Ichimura et al., 2000; Kabeya
et al., 2000). In the other ubiquitin-like system, Atg12
gets coupled via its C-terminal glycine residue (G140) to
a lysine residue of Atg5 by the E1- and E2-like enzymes
Atg7 and Atg10. The Atg12-Atg5 complex associates
with Atg16 and then binds to the outer surface of the iso-
lation membrane. Upon completion of the autophago-
some, the Atg5-Atg12-Atg16 complex dissociates from
the outer autophagosomal membrane (Mizushima et al.,
1998).
The exact functions of the components of the molecular
machinery for macroautophagy are not well understood to
date. Because the Atg5-Atg12-Atg16 complex localizes to
the convex surface of the isolation membrane, it mayImmunity 27, July 2007 ª2007 Elsevier Inc. 11
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through a protein lattice, not unlike what clathrin coating
does for endosomes (Trombetta and Mellman, 2005).
Furthermore, because Atg8 (LC3) is primarily localized to
the inner autophagosomal membrane, especially after
autophagosome completion, it was proposed that this
molecule could serve as an anchor for autophagy
substrates. Two proteins, Alfy and p62 (also known as
SQSTM1), have been suggested for the targeting of
Figure 1. Molecular Machinery of Macroautophagy
Atg6 (Beclin-1) is part of the type III PI3K complex that initiates auto-
phagosome formation. Two ubiquitin-like systems are required for for-
mation of the isolation membrane and couple Atg8 (LC3) and Atg12 to
phosphatidylethanolamine (PE) and Atg5, respectively. The five C-ter-
minal amino acids of Atg8 (LC3) are cleaved of by Atg4 to reveal glycine
120 (G120), which is required to link the protein after activation by Atg7
and ligation by Atg3 to PE in the autophagosomal membrane (green
circles). Similarly, glycine 140 (G140) is used by Atg7 and Atg10 to cou-
ple Atg12 to Atg5. This complex then localizes to the outer membrane
of the forming autophagosome (blue squares). Upon autophagosome
completion, the Atg12-Atg5 complex recycles from the outer mem-
brane, and only Atg8 (LC3) remains associated with the completed au-
tophagosome. Autophagosomes then fuse with late endosomes and
lysosomes for degradation of their cargo and their intravesicular mem-
branes.12 Immunity 27, July 2007 ª2007 Elsevier Inc.proteins to autophagosomes (Bjorkoy et al., 2005; Simon-
sen et al., 2004). Alfy has been found in proximity to auto-
phagic membranes and colocalizing with protein aggre-
gates under conditions of starvation and proteasome
inhibition, which are known to upregulate macroauto-
phagy (Mizushima and Klionsky, 2007; Simonsen et al.,
2004). Similarly, p62 (SQSTM1) has been found to localize
to protein aggregates, is degraded by macroautophagy,
and could be coimmunoprecipitated with Atg8 (LC3)
(Bjorkoy et al., 2005). Both proteins were suggested to
target protein aggregates to autophagosomes, in the
case of p62 (SQSTM1) by binding to Atg8 (LC3).
These studies on the molecular mechanisms of auto-
phagy and its importance in protein metabolism have
set the stage to analyze its importance during immune
responses. In the following sections, we will discuss auto-
phagy during innate immune responses to viruses, bacte-
ria, and parasites and highlight its role in the initiation and
execution of adaptive immune responses.
Escape from Autophagy by Viruses
Viral immune escape from proteasomal degradation has
been characterized in great detail (Tortorella et al.,
2000). In contrast, the interaction between viruses and
the autophagic machinery is just beginning to be eluci-
dated. The three following main outcomes of these inter-
actions have been noted: Macroautophagy successfully
limits viral replication, viruses inhibit macroautophagy to
avoid restriction of their replication, or viruses use accu-
mulated autophagosomes for their replication (Figure 2).
Only two studies have demonstrated so far that macro-
autophagy can successfully limit viral replication. One ex-
ample comes from plant infection by the tobacco mosaic
virus (TMV). This single-stranded RNA virus of the Toba-
movirus family replicates more efficiently when Atg6 (Be-
clin-1) or Atg7 are silenced in Nicotiana benthamiana
plants (Liu et al., 2005). The second example is a single-
stranded RNA virus of the Togavirus family. Sindbis virus
of this virus family causes encephalitis, which can be ame-
liorated by overexpression of Atg6 (Beclin-1) in mice
(Liang et al., 1998). After virus-driven Atg6 (Beclin-1) over-
expression, less Sindbis virus RNA-positive cells,
decreased brain pathology, and lower viral titers are de-
tected in mice. Although the role of constitutive macro-
autophagy in Sindbis-virus-mediated encephalitis has
not been elucidated so far, enhanced macroautophagy
seems to confer protection against viral replication. An-
other protective role that macroautophagy seems to play
during viral infections is to deliver pathogen constituents
for detection by endosomal receptors that initiate immune
responses, such as toll-like receptors (TLRs) (Lee et al.,
2007). One member of this family, TLR7, detects single-
stranded RNA. In the case of vesicular stomatitis virus
(VSV) and Sendai virus (SV) infection, TLR7-dependent
activation of plasmacytoid dendritic cells (pDCs) and their
type I IFN secretion seem to rely on macroautophagy be-
cause Atg5-deficient pDCs are unable to secrete IFN-a in
response to SV and VSV infection. However, further stud-
ies are required to ensure that pDC function is not
Immunity
Reviewgenerally compromised in the absence of macroauto-
phagy and to analyze to what extent this pathway contrib-
utes to the detection of viral infections in vivo.
In contrast to these examples of protection from viral
infection via macroautophagy, two double-stranded
DNA viruses of the herpesvirus family, herpes simplex
virus-1 (HSV-1) and Kaposi’s sarcoma-associated her-
pesvirus (KSHV), escape the fate of restriction or detection
by macroautophagy via expression of inhibitors of this
pathway. Both viruses target Atg6 (Beclin-1) for this pur-
pose. HSV-1 expresses the early-antigen, infected cell
protein 34.5 (ICP34.5), which inhibits macroautophagy
and thereby allows increased viral replication in mouse
Figure 2. Innate Immune Control by Macroautophagy
Viruses, bacteria, and parasites get cleared or interfere with their de-
struction by macroautophagy. Herpesviruses encode inhibitors of au-
tophagosome formation, whereas picornaviruses and coronaviruses
inhibit fusion of autophagosmes with lysosomes in order to replicate
on autophagosomal membranes.Rickettsia conorii and group AStrep-
tococcus, examples of bacterial pathogens that escape the endo-
some, are degraded by macroautophagy, but Shigella flexneri has
developed an escape strategy that avoids its import into autophago-
somes. Brucella abortus and Legionella pneumophila block autopha-
gosome-lysosome fusion and replicate in autophagic vesicles. Patho-
gens such as Toxoplasma gondii and Mycobacterium tuberculosis
condition phagosomes as replication niches, which can be cleared
by macroautophagy after immune activation of the host cell.embryonic fibroblasts (Tallo´czy et al., 2002). Interestingly,
recombinant HSV-1 with a mutant ICP34.5 protein that
can no longer interact with Atg6 (Beclin-1) and thereby
fails to inhibit macroautophagy is severely attenuated
with respect to neurovirulence in mice (Orvedahl et al.,
2007). This suggests that macroautophagy inhibition is
essential for efficient replication of HSV-1 in the central
nervous system of mice in vivo. Atg6 (Beclin-1) is also the
target of macroautophagy inhibition by KSHV. Its Bcl-2
homolog binds to Atg6 (Beclin-1) and thus inhibits macro-
autophagy (Pattingre et al., 2005), but it remains unclear
whether this function is important for KSHV replication.
An even more dramatic subversion of macroautophagy
is practiced by several single-stranded RNA viruses,
which replicate in the cytoplasm. Picornaviruses (poliovi-
rus and rhinoviruses), coronaviruses (mouse hepatitis
virus and severe acute respiratory syndrome coronavirus),
and one arterivirus (equine arteritis virus) replicate on the
surface of autophagosomal membranes (Dales et al.,
1965; Jackson et al., 2005; Pedersen et al., 1999; Prentice
et al., 2004a; Prentice et al., 2004b). These viruses proba-
bly block the fusion of autophagosomes, which carry their
replication complexes, with lysosomes. In the case of
poliovirus and rhinoviruses, this macroautophagy regula-
tion seems to be brought about by the 2BC and 3A pro-
teins, which are sufficient to induce the accumulation of
autophagosomes (Jackson et al., 2005). Generation of au-
tophagic membranes as scaffolds for the replication ma-
chinery is essential because inhibition of macroautophagy
by siRNA-mediated silencing of Atg12 or Atg8 (LC3) in-
hibits viral replication (Jackson et al., 2005). Therefore,
a number of single-stranded RNA viruses interfere with
autophagosome maturation in order to replicate on the
surfaces of these vesicles. Similarly, to their benefit, the
double-stranded RNA virus rotavirus of the reovirus family
and the single-stranded DNA virus B19 parvovirus both in-
duce macroautophagy, with rotavirus mediating this effect
via its NSP4 protein (Berkova et al., 2006; Nakashima
et al., 2006). Rotavirus seems to replicate in close proxim-
ity to autophagic membranes, and B19 parvovirus might
prolong the survival of infected cells via macroautophagy.
However, the exact function of macroautophagy induction
by these two viruses is not entirely understood.
Although all viruses listed above regulate macroauto-
phagy to promote their own replication, two other viruses
use the molecular macroautophagy machinery differently
for their benefit. Human immunodeficiency virus 1 (HIV-1)
induces autophagy-dependent apoptosis or autophagic
cell death in bystander CD4+ T cells when the envelope
protein of HIV-1 interacts with the chemokine receptor
CXCR4 on the cell surface of CD4+ T cells (Espert et al.,
2006). By these means, HIV-1 might deplete the CD4+
T cell compartment beyond destruction through viral rep-
lication. Another way in which a virus can benefit from
the macroautophagy machinery is demonstrated by the
single-stranded RNA virus bovine viral diarrhea virus
(BVDV) of the flavivirus family. This virus has incorporated
part of the Atg8 (LC3) sequence for specific proteolytic
processing of its polyprotein (Meyers et al., 1998),Immunity 27, July 2007 ª2007 Elsevier Inc. 13
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Atg8 (LC3) for coupling to autophagosomal membranes
(Figure 1). In this fashion, the virus uses a specific proteo-
lytic event of the macroautophagy machinery to process
its protein products.
Thus, both viruses and their hosts have evolved various
ways to utilize or subvert macroautophagy for their bene-
fit. The many pathways by which viruses target this
catabolic process suggest that it is important for innate
immunity against these pathogens.
Autophagic Defense against Intracellular Bacteria
and Parasites
In contrast to viruses, a number of microbial pathogens
have been described to be successfully targeted by mac-
roautophagy during innate immune responses. However,
most of these studies have been performed in vitro, and
it remains to be established whether macroautophagy
can restrict bacteria and parasites in vivo.
Bacteria and parasites have been found to be suscepti-
ble to macroautophagy in two cellular compartments after
entering their host cells. Free bacteria in the cytosol can
fall prey to macroautophagy, and pathogen-conditioned
phagosomes can either fuse with or get engulfed by auto-
phagosomes (Figure 2). Group A Streptococci multiply
freely in atg5/mouse embryonic fibroblasts after escap-
ing from endosomes (Nakagawa et al., 2004). In contrast
in wild-type cells, cytosolic group A Streptococci become
enveloped by autophagosomes and are delivered for lyso-
somal hydrolysis. Similarly, the cytoplasmic bacterium
Rickettsia conorii was observed in autophagosomal struc-
tures in endothelial cells by electron microscopy (Walker
et al., 1997). Proinflammatory cytokines lead to increased
macroautophagy and Rickettsia clearance from the cyto-
plasm. However, it has not been conclusively shown that
the protective cytokines required autophagy for restriction
of Rickettsia. Furthermore, metabolic inhibition of Listeria
monocytogenes after phagosome lysis renders these bac-
teria susceptible for macroautophagy and lysosomal
clearance (Rich et al., 2003). Engulfment of Listeria can
be blocked by pharmacological autophagy inhibitors
and accelerated by starvation. In addition to eliminating
pathogens in the cytosol, macroautophagy can also target
phagosomes that have been conditioned by bacteria or
parasites to avoid fusion with lysosomes. The best-stud-
ied examples for these are Mycobacterium tuberculosis
and Toxoplasma gondii (Andrade et al., 2006; Gutierrez
et al., 2004; Ling et al., 2006). M. tuberculosis was shown
to be cleared from mouse macrophages and a human
macrophage cell line by macroautophagy (Gutierrez
et al., 2004; Singh et al., 2006). Starvation-induced clear-
ance of the M. tuberculosis variant bovis BCG is inhibited
by pharmacological inhibitors of macroautophagy. In
addition to starvation, lipopolysaccharide (LPS)-induced
autophagic clearance of M. tuberculosis-containing
phagosomes via TLR4-TRIF-RIP1-p38MAPK signaling
(Xu et al., 2007 [this issue of Immunity]) has been ob-
served. An autophagy-dependent protective mechanism
is the lysosomal generation of bactericidal peptides from14 Immunity 27, July 2007 ª2007 Elsevier Inc.ubiquitin after autophagic delivery of ubiquitinylated pro-
tein aggregates (Alonso et al., 2007). The induction of au-
tophagy by starvation resulted in enhanced delivery of
ubiquitinated proteins to microbacteria-harboring phago-
somes and increased the bactericidal activity of lyso-
somes. Similarly, T. gondii appears to be susceptible to
macroautophagic degradation in mouse and human mac-
rophages (Andrade et al., 2006; Ling et al., 2006). Clear-
ance of T. gondii tachyzoites upon macrophage activation
could be inhibited by pharmacological inhibitors of macro-
autophagy and siRNA silencing of Atg6 (Beclin-1). Less
well characterized is the macroautophagic degradation
of Salmonella enterica and uropathogenic Escherichia
coli-containing vacuoles (Amer et al., 2005; Birmingham
et al., 2006). However, S. enterica at least seems to stim-
ulate macroautophagy via injection of its SipB protein into
the cytosol through the bacterial type III secretion system
(Hernandez et al., 2003).
As summarized above for viruses, bacteria have also
developed counteracting mechanisms against innate re-
striction by macroautophagy. Again, both autophago-
some generation and maturation into autolysosomes are
targeted (Figure 2). However, unlike viruses, these mech-
anisms do not seem to generally inhibit macroautophagy
of the host cell in trans but rather prevent autophagic
clearance of the particular bacterial pathogens in cis, with-
out affecting the degradation of other autophagy sub-
strates. Shigella flexneri inhibits macroautophagy, which
is induced by the binding of its VirG protein to Atg5
(Ogawa et al., 2005). This specific interaction of the auto-
phagic machinery with a bacterial protein is disrupted by
Shigella’s IcsB protein, and loss of IcsB leads to auto-
phagic clearance of these bacteria from the cytosol. A
number of other bacterial and parasitic pathogens trigger
macroautophagy for their efficient replication. Instead of
using autophagosomal membranes as scaffolds for repli-
cation, as discussed above for single-stranded RNA vi-
ruses, they replicate most effectively inside autophago-
somes and autolysosomes. Pathogens of this category
include Francisella tularensis, Brucella abortus, Porphyro-
monas gingivalis, Leishmania mexicana, Chlamydia tra-
chomatis, Coxiella burnetii, and Legionella pneumophila
(Al-Younes et al., 2004; Amer and Swanson, 2005; Celli
et al., 2003; Checroun et al., 2006; Dorn et al., 2001; Gu-
tierrez et al., 2005; Pizarro-Cerda et al., 1998; Schaible
et al., 1999). At least some of these bacteria use their
type III and type IV secretion systems to trigger autophagy
and also inhibit fusion of autophagosomes with lysosomes
to generate their replication niche. For example, 10–30
kDa components of Legionella type IV secretion sub-
strates are able to stimulate macroautophagy in mouse
macrophages (Amer and Swanson, 2005). In contrast,
the type IV secretion system of Brucella is required to pre-
vent fusion of the vesicular Brucella replication compart-
ment with lysosomes (Celli et al., 2003). Establishment of
this compartment can be inhibited by pharmacological in-
hibitors of macroautophagy (Pizarro-Cerda et al., 1998).
Thus, by using their elaborate secretion systems, suc-
cessful bacterial pathogens can subvert macroautophagy
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dation in their host cells.
Apart from pathogen clearance, macroautophagy pro-
vides another type of protection from bacterial pathogen-
esis during Vibrio cholerae infection. This noninvasive
intestinal pathogen secretes the hemolytic exotoxin cyto-
lysin, but gut epithelial cell lines resist cell death induced
by this toxin through the induction of macroautophagy
(Gutierrez et al., 2007). Atg5-deficient cells on the contrary
displayed poor survival upon exposure to Vibrio cytolysin.
Thus, bacterial pathogens, both after escaping from
endosomes into the cytosol and in phagosomes, can
become substrates for macroautophagy. The efficiency
of this innate immune defense mechanism most probably
forced successful bacterial pathogens to develop escape
mechanisms against autophagic degradation.
Antigen Presentation via Autophagy
In addition to limiting pathogen replication in host cells,
macroautophagy also delivers viral, parasitic, and bacte-
rial antigens to late endosomal compartments, where
macroautophagy substrates are then degraded by
lysosomal hydrolases. The fusion vesicles between auto-
phagosomes and late endosomes, the so-called amphi-
somes, have been isolated and ultrastructurally character-
ized by electron microscopy (Berg et al., 1998; Liou et al.,
1997). In these studies, double-membrane-enveloped
autophagosomes receive colloidal gold after endocytosis,
and the resulting amphisomes could be stabilized by inhi-
bition of lysosomal degradation. The amphisomes display
multivesicular and multilamellar morphology. Exactly the
same characteristics have been reported for major histo-
compatibility complex (MHC) class II loading compart-
ments (MIICs) (Zwart et al., 2005), which are now consid-
ered to be conventional late endosomes that are equipped
with the molecular machinery to load antigenic fragments
onto MHC class II molecules for presentation to CD4+
T cells.
We have recently shown that GFP-Atg8 (GFP-LC3)-
positive autophagosomes fuse frequently with MIICs, as
identified by the presence of MHC class II, the lysosomal
membrane protein LAMP-2 and the chaperone HLA-DM,
which is involved in peptide loading onto MHC class II
molecules (Schmid et al., 2007). We observe 50%–80%
overlap between Atg8 (LC3) and MHC class II in profes-
sional antigen-presenting cells, such as dendritic cells
and B cell lines, as well as epithelial cell lines, in which
MHC class II expression was induced by proinflammatory
cytokines. This cell-biological evidence suggests that
macroautophagy frequently delivers autophagosome
content, including pathogen-derived proteins, to MIICs
(Figure 3).
Biochemical isolation of natural MHC class II ligands re-
veals that up to 20% of eluted peptides originate from cy-
tosolic and nuclear proteins (Chicz et al., 1993; Dengjel
et al., 2005; Dongre et al., 2001; Rammensee et al.,
1999). Among them, two fragments of Atg8 (LC3)
(MAP1LC3B93-109 and MAP1LC3B93-110) have been iso-
lated from HLA-DR molecules of Epstein Barr virus(EBV)-transformed B cell lines (Dengjel et al., 2005). Other
sources of natural MHC class II ligands also fit the charac-
teristics of autophagy substrates. Some long-lived pro-
teins, which appear to be preferentially degraded by au-
tophagy (Henell et al., 1987), have been frequently found
to give rise to MHC class II peptide cargo. For example,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
with the extraordinarily long half-life of 130 hr (Dice and
Goldberg, 1975) has been described as a substrate of
chaperone-mediated autophagy (Aniento et al., 1993)
and has been isolated from autophagosomes (Fengsrud
et al., 2000b). In good agreement with autophagic delivery
of antigens for MHC class II loading, GAPDH-derived pep-
tides have been isolated from four different MHC class II
molecules, but no natural MHC class I ligands have
Figure 3. Role of Macroautophagy in Adaptive Immune
Responses
Autophagic pathways can deliver antigens for MHC class II presenta-
tion. Autophagosomes and LAMP-2a, the transporter associated with
chaperone-mediated autophagy, can transport antigens into the
MHC-class-II-loading compartment (MIIC). In MIICs, the antigen is
processed and loaded onto MHC class II molecules for CD4+ T cell
stimulation. Activated CD4+ T cells can then in turn enhance macro-
autophagy and autophagosome-lysosome fusion via type II IFN and
TNF family members (IFN-g, TNF, TRAIL, and CD40L). In addition,
Th2-polarized CD4+ T cells are susceptible to cell death by macro-
autophagy.Immunity 27, July 2007 ª2007 Elsevier Inc. 15
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1999). In contrast, cyclins with half-lives in the order of
minutes are one of the most frequent sources of MHC
class I peptides and have been eluted from 17 different
MHC class I molecules, but only one MHC class II ligand
from this group of proteins has been described so far
(Rammensee et al., 1999). Short and long half-life corre-
late to some extent with the degradation route of proteins.
For example, the nuclear antigen 1 of EBV (EBNA1) con-
tains a glycine alanine (GA)-repeat domain, which inhibits
its degradation via the proteasome and presentation on
MHC class I (Hoyt et al., 2006; Lee et al., 2004; Levitskaya
et al., 1995; Levitskaya et al., 1997). EBNA1’s half-life is
very long (Levitskaya et al., 1997; Tellam et al., 2001) but
is shortened considerably upon deletion of the GA repeat
(Levitskaya et al., 1997). GA-deleted EBNA1 is degraded
by the proteasome and efficiently presented on MHC
class I (Lee et al., 2004; Levitskaya et al., 1997). In con-
trast, long-lived wild-type EBNA1 is presented on MHC
class II after macroautophagy (Paludan et al., 2005). Sim-
ilarly, influenza matrix protein 1 (MP1) is intracellularly
processed onto MHC class II (Jaraquemada et al.,
1990), but when the half-life of MP1 is shortened by
N-end-rule modification with enhanced proteasomal deg-
radation, endogenous MHC class II presentation is lost
(Gueguen and Long, 1996).
Further evidence, consistent with the hypothesis that
proteins with long half-lives are preferentially processed
for MHC class II presentation, comes from analysis of
the RAD23 protein. Not unlike EBNA1, this protein con-
tains a domain that prevents proteasomal proteolysis
(Heessen et al., 2005). Deletion of this UBA2 domain
shortens RAD23’s half-life and makes it more susceptible
to proteasomal degradation. Interestingly, when auto-
phagy is induced by starvation and then natural HLA-DR
ligands are eluted, peptides derived from cytosolic and
nuclear antigens are upregulated, whereas natural ligands
from membrane and secreted proteins are not affected
(Dengjel et al., 2005). A protein whose MHC class II pre-
sentation is strongly upregulated after 24 hr of starvation
is RAD23. Taken together, all these examples suggest
that long-lived autophagy substrates are efficiently pro-
cessed for MHC class II presentation to CD4+ T cells.
CD4+ T Cell Stimulation after Autophagy
Direct involvement of the molecular machinery for auto-
phagy in intracellular antigen presentation on MHC class
II has been documented only for a few antigens so far.
The first study implicating macroautophagy in antigen
processing onto MHC class II demonstrated that phar-
macological inhibition of autophagosome formation de-
creased MHC class II presentation of the overexpressed
complement C5 protein in mouse macrophage and B
cell lines (Brazil et al., 1997). In this study and many
follow-up studies, inhibitors of the class III PI3 kinase
complex, including 3-methyladenine (Seglen and Gordon,
1982), have been used to inhibit macroautophagy.
However, 3-methyladenine has additional effects on
membrane trafficking such as endocytosis, on lysosomal16 Immunity 27, July 2007 ª2007 Elsevier Inc.acidification, on phosphorylation of some signal transduc-
tion molecules, and on mitochondrial permeability (Miz-
ushima, 2004). Therefore, pharmacological inhibition of
macroautophagy can be used as a first indication that
this pathway is involved, but this finding should be con-
firmed by RNA interference or in knockout cells. With
these caveats of pharmacological inhibitors in mind, two
additional studies have used those to implicate macroau-
tophagy in intracellular MHC class II antigen processing of
the tumor antigen Mucin gene 1 (MUC1) product (Do¨rfel
et al., 2005) and the model antigen neomycin phospho-
transferease II (NeoR) (Nimmerjahn et al., 2003). Of these,
the latter study controlled, as carefully as possible, for
macroautophagy-independent side effects of the phar-
macological inhibitors by demonstrating that CD8+ T cell
recognition of the tumor antigen tyrosinase and MHC
class II antigen processing of extracellular NeoR were
not influenced by 3-methyladenine. In addition, NeoR
accumulated intracellularly and was excluded from
delivery to lysosomes by this treatment. Therefore, the
authors provided good evidence that NeoR is delivered
by macroautophagy for MHC class II presentation in
EBV-transformed B cells and in renal cell carcinoma cells.
In addition to these studies on self, tumor, and model
antigens, we have demonstrated that the viral antigen
EBNA1 is processed intracellularly for MHC class II pre-
sentation to CD4+ T cells via macroautophagy in EBV-
transformed B cells and EBNA1-transfected EBV-nega-
tive Hodgkin’s lymphoma cells (Mu¨nz et al., 2000; Paludan
et al., 2005). Upon inhibition of lysosomal degradation, we
have found EBNA1 accumulating in autophagosomes,
visualized as multiple membrane-enveloped vesicles or
isolation membranes in electron microscopy. Further-
more, intracellular EBNA1 processing for MHC class II
presentation is inhibited by siRNA-mediated silencing of
the essential autophagy gene Atg12. According to these
data, EBNA1 is the first antigen for which physiological
amounts have been demonstrated to be processed onto
MHC class II after macroautophagy. More recently, we
have shown that targeting of influenza MP1 to autophago-
somes by fusing this antigen to Atg8 (LC3) enhanced MHC
class II presentation to MP1-specific CD4+ T cell clones 5-
to 20-fold, whereas MHC class I presentation to MP1-
specific CD8+ T cell clones was not affected by attach-
ment to Atg8 (LC3) (Schmid et al., 2007). We have
observed increased MP1-Atg8 (MP1-LC3) presentation
on MHC class II in epithelial cells, EBV-transformed B lym-
phoblastoid cells, and dendritic cells. Targeting of the
fusion antigen for MHC class II presentation is dependent
on coupling of MP1-Atg8 (LC3) to the autophagosomal
membrane because a mutant protein lacking the glycine
residue (Gly120) used for the ubiquitin-like conjugation
reaction does not show enhanced MHC class II presenta-
tion. Furthermore, inhibition of macroautophagy by RNA
silencing of Atg12 inhibited MP1-Atg8 (LC3) transport to
vesicles that are MHC class II positive. Taken together,
these data suggest that several antigens can enter the
MIIC via macroautophagy and that this pathway leads to
efficient MHC class II presentation to CD4+ T cells.
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ReviewIn addition to macroautophagy, chaperone-mediated
autophagy has also been implicated in delivering cytosolic
antigens for MHC class II presentation (Figure 3). The two
autoantigens glutamate decarboxylase 65 (GAD65) and
the mutant human immunoglobulin k chain SMA showed
enhanced processing onto MHC class II after overexpres-
sion of LAMP-2a, the transporter of chaperone-mediated
autophagy (Zhou et al., 2005). Because MHC class II pro-
cessing of these antigens also requires proteasomal and
calpain-mediated degradation (Lich et al., 2000), Zhou
and colleagues suggested that these autoantigens are
processed into peptides in the cytosol and then are
imported into MIICs by LAMP-2a. Thus, both macro-
autophagy and chaperone-mediated autophagy can de-
liver cytosolic and nuclear antigens into MIICs for efficient
MHC class II presentation to CD4+ T cells. Future studies
now need to address to which extent these pathways con-
tribute to CD4+ T cell responses in vivo.
Role of Autophagy in CD4+ T Cell Immunity
and Tolerance
CD4+ T cell stimulation after autophagy-mediated antigen
processing could be crucial both during steady-state tol-
erance induction and immune control of pathogens and
tumors. Self-antigen presentation on MHC class II of
both thymic epithelial cells and dendritic cells could lead
to central and peripheral tolerance maintenance in the
CD4+ T cell compartment. In agreement with this hypoth-
esis, thymic epithelia display great amounts of autopha-
gosomes in the GFP-LC3 transgenic macroautophagy re-
porter mouse in the steady state (Mizushima et al., 2004).
Interestingly, more autophagosomes could be found in
this tissue in newborns than in adult mice. These findings
correlate with T cell selection and central tolerance induc-
tion for CD4+ T cells being most active at a young age
(Starr et al., 2003). In addition, we find considerable au-
tophagy in immature dendritic cells (Schmid et al., 2007),
which have been implicated in peripheral tolerance induc-
tion (Steinman et al., 2003). Some of these tolerance
mechanisms might be compromised in patients with mu-
tations in Atg16 and Crohn disease (Hampe et al., 2007;
Rioux et al., 2007). This inflammatory bowel disease oc-
curs in individuals with genetic predisposition and is prob-
ably triggered by the enteric microflora. Therefore, de-
creased macroautophagy due to Atg16 mutations might
either impair innate resistance to invading bacteria in in-
testinal epithelial cells and thereby trigger inflammation
as a result of increased antigenic load or lead to insuffi-
cient tolerance induction against commensals in the gut
and trigger Crohn disease. On the basis of these findings,
it is tempting to speculate that macroautophagy might
contribute to self-antigen presentation during central
and peripheral tolerance maintenance for CD4+ T cells.
CD4+ T cells are crucial orchestrators of adaptive immu-
nity. Their activation is required for both B cell differentia-
tion and immunoglobulin maturation during humoral im-
munity, as well as efficient noninflammatory CD8+ T cell
priming and maintenance of CD8+ T cell function during
cell-mediated immunity (Bevan, 2004; McHeyzer-Williamsand McHeyzer-Williams, 2005). In addition, CD4+ T cells
can have direct effector functions against infected and
transformed cells (Heller et al., 2006). Therefore, auto-
phagic delivery of intracellular antigens for MHC class II
presentation could lead to efficient CD4+ T cell priming
by infected professional antigen-presenting cells, such
as dendritic cells. This mechanism could also contribute
to CD4+ T cell immune surveillance of inflamed tissues,
which upregulate MHC class II upon exposure to pro-
inflammatory cytokines (Reith and Mach, 2001), as we
observed for epithelial cells (Schmid et al., 2007).
Taken together, the discussed findings show that intra-
cellular antigen processing via autophagy broadens the
immunological functions and usefulness of MHC class II
presentation. This pathway expands the traditional view
that MHC class II presentation is restricted to professional
antigen-presenting cells with considerable endocytic ac-
tivity to the new paradigm that MHC class II molecules
also enable immune surveillance and tolerance induction
for intracellular antigens during immune activation and in
the steady state. Therefore, MHC class II might play
a much broader role, similar to MHC class I, at sites of
inflammation and MHC class II upregulation.
Autophagy Regulation as an Effector Mechanism
of the Adaptive and Innate Immune System
In addition to macroautophagy as an innate immune
mechanism in infected host cells, this pathway is also in-
duced as an effector mechanism of innate and adaptive
lymphocytes via interferons (IFNs) and members of the
tumor necrosis factor (TNF) family (Figure 3).
Both type I and II IFNs have been reported to modulate
macroautophagy. Restriction of HSV-1 infection by macro-
autophagy in vitro and in vivo was found to be dependent
on the type I IFN-inducible double-stranded-RNA-
dependent protein kinase R (PKR) (Orvedahl et al., 2007;
Tallo´czy et al., 2002). In order to develop neurovirulence,
HSV-1 carries the ICP34.5 protein, which inhibits PKR-
dependent macroautophagy induction by binding to
Atg6 (Beclin-1) (Orvedahl et al., 2007). Type II IFN has
been reported to enhance Mycobacterium tuberculosis
and Ricksettia conorii degradation by macroautophagy
in infected cells (Gutierrez et al., 2004; Singh et al., 2006;
Walker et al., 1997). Mouse macrophages seem to be
most susceptible to IFN-g-induced upregulation of mac-
roautophagy, whereas in human tissues, this effect is
more difficult to demonstrate and probably proceeds
with slower kinetics (Pyo et al., 2005). Type II IFN seems
to induce macroautophagy and mycobacterial clearance
through immunity-related GTPases (IRGs), also known
as p47 GTPases, including the mouse LRG-47 and the
human IRGM proteins. Mouse tissues are probably more
susceptible to this macroautophagy regulation mecha-
nism because their IRGs are IFN-g inducible, whereas
the human IRG is not. In addition, IFN-g might also induce
macroautophagy via death-associated protein kinases
(DAPk). Overexpression of DAPk and its close family
member DAPk-related protein kinase (DRP)-1 has been
shown to increase macroautophagy in human epithelialImmunity 27, July 2007 ª2007 Elsevier Inc. 17
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signaling pathways, these studies suggest that not only
infected cells can upregulate macroautophagy via IFN-
a and IFN-b but also potent type I IFN producers such
as pDCs, as well as IFN-g-secreting natural killer (NK)
and T cells, might induce clearance of intracellular patho-
gens and enhance MHC class II presentation in infected
tissues via this pathway.
Macroautophagy induction via TNF family members has
been primarily investigated in cell-death research. The
interplay between autophagy and apoptosis underlying
these studies has been recently reviewed (Kroemer and
Jaattela, 2005). First, TNF-a itself was found to upregulate
macroautophagy in cells lacking NF-kB activation (Djava-
heri-Mergny et al., 2006). Second, TNF-related apopto-
sis-inducing ligand (TRAIL) was described to induce
autophagy in human epithelial cells (Mills et al., 2004).
Consistent with this, inactivation of Fas-associated death
domain (FADD), the signaling adaptor protein of the TRAIL
receptor, decreases autophagy induction by TRAIL (Thor-
burn et al., 2005). As a third TNF family member, CD40L
has been demonstrated to induce macroautophagy-medi-
ated fusion of Toxoplasma gondii-containing phagosomes
with lysosomes via CD40 signaling on mouse and human
macrophages (Andrade et al., 2006). RNA silencing of
Atg6 (Beclin-1) inhibited CD40-mediated clearance of
T. gondii. Various cell types of the innate and adaptive im-
mune system could potentially use this macroautophagy
induction that is TNF family member mediated, including
TNF-a-secreting dendritic cells, TRAIL-expressing NK
and T cells, and CD40L-presenting CD4+ T cells. However,
future studies are required to investigate whether macro-
autophagy induction during immune responses contrib-
utes substantially to resistance against infections in vivo.
Regulation of T Cell Survival and Death
by Macroautophagy
Dendritic cells and NK and T cells might induce macro-
autophagy in infected cells to fight infections, but at the
same time the fate of these immunological effectors
seems to be determined by their own capacity to perform
macroautophagy. The extent to which this process con-
tributes to cell survival and cell death has so far primarily
been investigated in T cells. Although the relationship be-
tween autophagy and apoptosis is still not entirely clear,
a picture is emerging that autophagy often precedes apo-
ptosis, often as a last rescue attempt before cell death
(Kroemer and Jaattela, 2005). In some instances, how-
ever, macroautophagy is required for cell death or can
even execute it, especially when the apoptosis machinery
is compromised. These different modulations of cell death
by macroautophagy are also reflected in studies on T cells
(Figure 3). Atg5 deficiency leads to decreased T and B cell
numbers in mice, and both CD4+ and CD8+ T cells fail to
undergo efficient proliferation upon T cell receptor stimu-
lation (Pua et al., 2007). These findings were interpreted as
macroautophagy playing a role in T cell maintenance dur-
ing the steady state and after activation. Furthermore, Th2
polarized CD4+ T cells, which are thought to support18 Immunity 27, July 2007 ª2007 Elsevier Inc.humoral immune responses most efficiently, display
more GFP-Atg8 (GFP-LC3)-positive autophagosomes
than Th1 cells, which have been shown to support cell-
mediated immunity better (Li et al., 2006). In this study,
the Th2 cell line D10 was more resistant to cell death
upon growth-factor withdrawal when macroautophagy
was inhibited by RNA silencing of Atg7 or Atg6 (Beclin-
1), whereas steady-state survival and proliferation were
not affected by macroautophagy inhibition. These studies
suggest that Th2-polarized CD4+ T cells either die by mac-
roautophagy or need the autophagy machinery to execute
apoptotic cell death upon growth-factor deprivation. The
latter interpretation is more likely because HIV-1 envelope
protein induces CD4+ T cell apoptosis via macroauto-
phagy and is inhibited upon RNA silencing of Atg7 or Atg6
(Beclin-1) (Espert et al., 2006). According to these studies,
macroautophagy seems to be more important for CD8+
than CD4+ T cell survival, and Th2-polarized CD4+ T cells
are more sensitive to cell death via macroautophagy than
Th1-polarized cells. These data suggest that when manip-
ulating macroautophagy for enhanced pathogen clear-
ance, one should keep in mind that cellular components
of the immune system, such as Th2 cells, might be sensi-
tive to cell-death induction via macroautophagy. There-
fore, any benefit gained by innate clearance of pathogens
in infected cells via macroautophagy enhancement might
be lost by compromising another arm of immune control,
including Th2-supported humoral immunity.
Conclusions and Future Perspectives
Previous studies on autophagy in innate and adaptive im-
mune responses have revealed interesting roles for this
pathway in innate and adaptive immunity. However, these
now need to be investigated in vivo. With the demonstra-
tion that macroautophagy inhibition is required for neuro-
virulence of HSV-1 in mice (Orvedahl et al., 2007), a step
into this direction has been taken, but more such in vivo
studies need to be performed. In vivo characterizations
of the role of autophagy during tolerance induction and
in dendritic cells for the initiation of immune responses
are of special interest. With conditional knockout mice
for essential macroautophagy genes (Hara et al., 2006;
Komatsu et al., 2006), siRNAs for silencing Atg genes
(Jackson et al., 2005; Schmid et al., 2007), and viral inhib-
itors of macroautophagy (Orvedahl et al., 2007; Pattingre
et al., 2005), these studies become feasible in mice. A
second important area is the investigation of substrate
characteristics for pathogen and antigen import into auto-
phagosomes. Although ubiquitination has been proposed
as an import signal for macroautophagy (Bjorkoy et al.,
2005), no firm evidence for this hypothesis has been pre-
sented. Finally, starvation-independent regulation of au-
tophagy, especially during infections, is just beginning to
become unraveled. A better understanding of this pro-
cess, however, is required to evaluate it for therapeutic
potential, especially because macroautophagy can not
only support cell survival and pathogen clearance but
also cell death. For manipulations of this pathway in
Immunity
Reviewpatients, one has to walk a fine line between evoking its
beneficial effects and avoiding tissue damage.
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